Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Copper × Clear all

Phase

Status

Completed 2 Withdrawn 1 Unknown 1 Terminated 1 Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

pembrolizumab 519 Specimen Handling 428 Carboplatin 393 Magnetic Resonance Spectroscopy 386 Cisplatin 367 Cyclophosphamide 350 Radiotherapy 325 Gemcitabine 276 Bevacizumab 268 Paclitaxel 258 Biopsy 252 Drug Therapy 245 Blood Specimen Collection 219 venetoclax 206 Nivolumab 204 fludarabine 202 Capecitabine 201 Oxaliplatin 195 Docetaxel 187 Injections 180 Fluorouracil 172 Radiosurgery 163 Dexamethasone 162 Rituximab 143 Pemetrexed 142 Surgical Procedures, Operative 136 Standard of Care 136 durvalumab 129 atezolizumab 127 tislelizumab 123

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03323346 2025-07-20

DISC

The Institute of Molecular and Translational Medicine, Czech Republic

Phase 2 Recruiting

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡